Bloomberg: Boris Johnson Stumbles Into Yet Another Crisis
Therese Raphael, columnist for Bloomberg Opinion (9/21).

The Conversation: Can COVID-19 inspire a new way of planning African cities?
Patrick Brandful Cobbinah, lecturer at the University of Melbourne; Ellis Adjei Adams, assistant professor at the University of Notre Dame; and Michael Odei Erdiaw-Kwasie, research fellow at the University of Southern Queensland (9/20).

Devex: Opinion: The short-sightedness of the COVID-19 vaccine race
Francesco Rocca, president of the International Federation of Red Cross and Red Crescent Societies and national president of the Italian Red Cross Association (9/18).

IPS: Peace is the North Star During and the Post COVID-19 Pandemic
Siddharth Chatterjee, U.N. resident coordinator to Kenya, and Walid Badawi, UNDP resident representative to Kenya (9/21).

NBC News: Dr. Kenneth Gorelick: Trump’s Covid-19 vaccine timeline is missing key context about logistics of herd immunity
Kenneth Gorelick, internal medicine and pulmonary disease specialist, member of the Committee to Protect Medicare, and head of Zymo Consulting Group (9/19).

New York Times: The Pandemic, From the Virus’s Point of View
David Quammen, author and journalist (9/19).

POLITICO: How Much Are We Paying to Treat Covid?
Nikki Haley, governor of South Carolina from 2011-2017 and U.S. ambassador to the United Nations from 2017-2019 (9/21).

Rewire.News: Why Making Sex Work Legal Would Help in the COVID-19 Fight
Deon Haywood, executive director, and Lakeesha Harris, director of reproductive health and justice, both at Women With A Vision, Inc. (9/18).

STAT: Three lessons from Covid-19 on accelerating biopharma innovation
Anne White, president of Lilly Oncology (9/18).

Wall Street Journal: You Can Trust the FDA’s Vaccine Process
Scott Gottlieb, FDA commissioner from 2017-2019 and board member of Pfizer, and Mark McClellan, FDA commissioner from 2002-2004 and board member of Johnson & Johnson (9/20).